Association between process performance measures and 1-year mortality among patients with incident heart failure: a Danish nationwide study.


Journal

European heart journal. Quality of care & clinical outcomes
ISSN: 2058-1742
Titre abrégé: Eur Heart J Qual Care Clin Outcomes
Pays: England
ID NLM: 101677796

Informations de publication

Date de publication:
01 01 2019
Historique:
received: 12 11 2017
accepted: 10 09 2018
pubmed: 12 9 2018
medline: 7 2 2019
entrez: 12 9 2018
Statut: ppublish

Résumé

To examine the association between fulfilment of performance measures supported by clinical guidelines recommendations and 1-year mortality among patients with incident heart failure (HF) in Denmark. A nationwide population-based follow-up study based on the Danish Heart Failure Registry. All Danish hospital departments caring for patients with HF. We identified 24 308 in- and outpatients diagnosed with HF from 2003 to 2010. Quality of care was defined as receiving the guideline recommended processes of care: use of echocardiography, New York Heart Association classification, treatment with angiotensin-converting-enzyme inhibitors/angiotensin-II-receptor blocker, beta blockers, physical training, and patient education. Main outcome measure is 1-year mortality. We used multiple imputation and multivariable Cox proportional hazard regression to compute hazard ratios (HRs) for 1-year mortality adjusted for potential confounding factors. Within 1 year, 17.1% of the patients died and the adjusted HRs ranged from 0.61 [95% confidence interval (CI) 0.55-0.67] for patient education to 0.99 (95% CI 0.90-1.10) for beta blocker therapy. The association between meeting more performance measures and 1-year mortality appeared to follow a dose-response pattern: using 0-25% of fulfilled measures as reference, patients who fulfilled 76-100% of the performance measures had an adjusted HR of 0.43 (95% CI 0.38-0.48), while the adjusted HR was 0.96 (95% CI 0.86-1.07) for patients who fulfilled between 26% and 50% of the performance measures. Meeting process performance measures, which reflect care in concordance with clinical guideline recommendations, was associated with substantially lower 1-year mortality among patients with incident HF.

Identifiants

pubmed: 30204858
pii: 5094885
doi: 10.1093/ehjqcco/qcy041
doi:

Substances chimiques

Adrenergic beta-Antagonists 0
Angiotensin II Type 1 Receptor Blockers 0
Angiotensin-Converting Enzyme Inhibitors 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

28-34

Commentaires et corrections

Type : CommentIn

Auteurs

Anne Nakano (A)

Department of Clinical Epidemiology, Aarhus University Hospital, 8200 Aarhus N, Olof Palmes Allé 43, Denmark.
Department of The Danish Clinical Registers, Audit Unit West, Olof Palmes Allé 15, Aarhus N, Denmark.

Nicklas Vinter (N)

Diagnostic Centre, University Research Clinic for Innovative Patient Pathways, Silkeborg Region Hospital, Falkevej 1G, Silkeborg, Denmark.
Danish Center for Clinical Health Services Research, Department of Clinical Medicine, Aalborg University and Aalborg University Hospital, Mølleparkvej 10, Aalborg, Denmark.

Kenneth Egstrup (K)

Department of Cardiology, Odense University Hospital, Svendborg Hospital, Baagøes Allé 15, Svendborg, Denmark.

Marie Louise Svendsen (ML)

Department of Clinical Epidemiology, Aarhus University Hospital, 8200 Aarhus N, Olof Palmes Allé 43, Denmark.
Data & Documentation, DEFACTUM, Olof Palmes Allé 17, Aarhus N, Denmark.

Inge Schjødt (I)

Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, Aarhus N, Denmark.

Søren Paaske Johnsen (SP)

Department of Clinical Epidemiology, Aarhus University Hospital, 8200 Aarhus N, Olof Palmes Allé 43, Denmark.
Danish Center for Clinical Health Services Research, Department of Clinical Medicine, Aalborg University and Aalborg University Hospital, Mølleparkvej 10, Aalborg, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH